Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026)
Planet 13 Holdings (PLNH) reported Depreciation & Amortization (CF) of $40259.0 for Q1 2026, down 98.69% year-over-year from $3.1 million in Q1 2025, and down 26.41% quarter-over-quarter from $54705.0 in Q4 2025.
Planet 13 Holdings (PLNH) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $40259.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $40259.0, down 98.69% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.9 million (down 121.55% YoY), and the FY2025 annual result was $135930.0, down 98.99% from the prior year.
- Depreciation & Amortization (CF) retreated to $40259.0 in Q1 2026 per PLNH's latest filing, from $54705.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $3.6 million in Q4 2024 and troughed at -$9.0 million in Q4 2023.
- A 5-year average of $808885.0 and a median of $3.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 173.95% in 2022, then tumbled 273.25% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at -$8.1 million in 2022, then retreated by 11.01% to -$9.0 million in 2023, then jumped by 139.67% to $3.6 million in 2024, then tumbled by 98.47% to $54705.0 in 2025, then fell by 26.41% to $40259.0 in 2026.
- Business Quant data shows PLNH's Depreciation & Amortization (CF) at $40259.0 in Q1 2026, $54705.0 in Q4 2025, and -$6.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | 40,259.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40,259.00 |
| Mar 31, 2026 | 40,259.00 |
| Dec 31, 2025 | 54,705.00 |
| Dec 31, 2025 | 54,705.00 |
| Sep 30, 2025 | -6.20 Mn |
| Sep 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | -9.04 Mn |
| Dec 31, 2023 | -9.04 Mn |